SCHEMBL166273

SCHEMBL166273

Cc1cc(Nc2nc(C(F)(F)c3ccc(F)cc3)nc3ccsc23)n[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAK1 Q13153 3/20 0.51
NTRK1 P04629 7/20 0.45
AURKB Q96GD4 3/20 0.44
AURKA O14965 2/20 0.44
NTRK3 Q16288 1/20 0.43
NTRK2 Q16620 1/20 0.43
DHODH Q02127 1/20 0.43
PAK4 O96013 2/20 0.42
PLK4 O00444 1/20 0.42
JAK2 O60674 5/20 0.41
JAK3 P52333 4/20 0.41
CYP3A4 P08684 3/20 0.41
CYP2C8 P10632 3/20 0.41
CYP2C9 P11712 3/20 0.41
JAK1 P23458 3/20 0.41
TYK2 P29597 3/20 0.41
CYP2C19 P33261 3/20 0.41
ADORA3 P0DMS8 2/20 0.41
CYP1A2 P05177 1/20 0.41
GSK3B P49841 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL177656 0.88 PAK1 (0.49) PAK1NTRK1AURKBAURKANTRK3
SCHEMBL167094 0.86 PAK1 (0.48) PAK1NTRK1AURKBAURKAJAK2
SCHEMBL173555 0.85 PLK4 (0.44) NTRK1AURKBAURKANTRK3NTRK2
SCHEMBL168897 0.84 NTRK1 (0.45) NTRK1AURKBAURKANTRK3NTRK2
SCHEMBL166022 0.83 NTRK1 (0.43) NTRK1AURKBAURKANTRK3NTRK2
SCHEMBL175070 0.83 AURKA (0.63) NTRK1AURKBAURKANTRK3NTRK2
SCHEMBL166231 0.82 NTRK1 (0.44) NTRK1AURKBAURKANTRK3NTRK2
SCHEMBL175046 0.82 PAK4 (0.33) PAK1AURKBPAK4JAK2GSK3B
SCHEMBL168759 0.82 NTRK1 (0.66) NTRK1AURKBAURKANTRK3NTRK2
SCHEMBL174009 0.81 NTRK1 (0.56) NTRK1AURKBAURKANTRK3NTRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611812-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2013-07-10 EP claimed
WO-2012030894-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO claimed
EP-2611812-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2013-07-10 EP disclosed
WO-2012030894-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO disclosed
WO-2012030894-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO disclosed